Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities
Net loss	$ (9,294,000)	$ (2,367,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	91,000	136,000
Reduction in SMCB loan in exchange for services	172,000
Provision for estimated cost of returns	870,000	658,000
Change in fair value of warrant liability	6,468,000
Provision for inventory obsolescence	4,000
Credit losses	3,000	101,000
Reserve for sales returns	(1,614,000)	(971,000)
Stock-based compensation	85,000	19,000
Changes in operating assets and liabilities:
Accounts receivable	2,986,000	3,902,000
Accounts receivable - related parties	(145,000)	136,000
Inventories	287,000	379,000
Prepaid expenses and other current assets	(6,000)	(78,000)
Accounts payable	(2,507,000)	(3,669,000)
Accrued expenses	(1,053,000)	(299,000)
Refunds due to customers	592,000	(300,000)
Prepaids from customers		(279,000)
Other liabilities	(47,000)	75,000
Net cash used in operating activities	(3,108,000)	(2,557,000)
Cash flows from investing activities
Advances to SMCB	(672,000)
Other	(1,000)
Net cash used in investing activities	(673,000)
Cash flows from financing activities
Repayment of note payable to related party	(473,000)
Other		(21,000)
Net cash used in financing activities	(473,000)	(21,000)
Net change in cash	(4,254,000)	(2,578,000)
Cash at beginning of year	7,550,000	6,703,000
Cash at end of period	3,296,000	4,125,000
Supplemental disclosures of cash flow information:
Cash paid for interest	17,000	27,000
Non-Cash investing and financing cash flow information:
Reclassification of Series A warrants to equity	7,857,000
Common stock issued for exercise of Series B warrants	15,214,000
Repurchase of common stock from related parties in exchange for promissory note	$ 758,000